| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |